A List

''A List'' is a play by American writer Gertrude Stein, written in 1923 and first published in ''Operas and Plays'' in 1932. It is structured in six parts, each labeled as a numbered or alphabetized "List," and has seven characters: Martha, Maryas, Marius, Mabel, Mary, Martin, and May. There are no explicit stage directions, but names in the side text are frequently joined with an ampersand or the word "and." Stein said that the play was based on Avery Hopwood's play ''Our Little Wife'' (1916). Provided by Wikipedia
Showing 1 - 15 results of 15 for search 'List, A', query time: 0.13s Refine Results
  1. 1
    Prism adaptation reverses the local processing bias in patients with right temporo-parietal junction lesions

    Prism adaptation reverses the local processing bias in patients with right temporo-parietal junction lesions by Bultitude, J, Rafal, R, List, A

    Published 2009
    Journal article
  2. 2
    Prism adaptation reverses the local processing bias in patients with right temporo-parietal junction lesions.

    Prism adaptation reverses the local processing bias in patients with right temporo-parietal junction lesions. by Bultitude, J, Rafal, R, List, A

    Published 2009
    Journal article
  3. 3
    Prism adaptation does not alter object-based attention in healthy participants.

    Prism adaptation does not alter object-based attention in healthy participants. by Bultitude, J, List, A, Davies, A

    Published 2013
    Journal article
  4. 4
    Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations.

    Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations. by Santini, V, Prebet, T, Fenaux, P, Gattermann, N, Nilsson, L, Pfeilstöcker, M, Vyas, P, List, A

    Published 2014
    Journal article
  5. 5
    Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS.

    Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS. by Keerthivasan, G, Mei, Y, Zhao, B, Zhang, L, Harris, C, Gao, J, Basiorka, A, Schipma, M, McElherne, J, Yang, J, Verma, A, Pellagatti, A, Boultwood, J, List, A, Williams, D, Ji, P

    Published 2014
    Journal article
  6. 6
    Integrating Philips' extreme UV source in the alpha-tools

    Integrating Philips' extreme UV source in the alpha-tools by Pankert, J, Apetz, R, Bergmann, K, Derra, G, Janssen, M, Jonkers, J, Klein, J, Krucken, T, List, A, Loeken, M, Metzmacher, C, Neff, W, Probst, S, Prummer, R, Rosier, O, Seiwert, S, Siemons, G, Vaudrevange, D, Wagemann, D, Weber, A, Zink, P, Zitzen, O

    Published 2005
    Conference item
  7. 7
    Persistent malignant stem cells in del(5q) myelodysplasia in remission.

    Persistent malignant stem cells in del(5q) myelodysplasia in remission. by Tehranchi, R, Woll, P, Anderson, K, Buza-Vidas, N, Mizukami, T, Mead, A, Astrand-Grundström, I, Strömbeck, B, Horvat, A, Ferry, H, Dhanda, R, Hast, R, Rydén, T, Vyas, P, Göhring, G, Schlegelberger, B, Johansson, B, Hellström-Lindberg, E, List, A, Nilsson, L, Jacobsen, SE

    Published 2010
    Journal article
  8. 8
    TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.

    TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients. by Caceres, G, McGraw, K, Yip, B, Pellagatti, A, Johnson, J, Zhang, L, Liu, K, Zhang, L, Fulp, W, Lee, J, Al Ali, N, Basiorka, A, Smith, L, Daugherty, F, Littleton, N, Wells, R, Sokol, L, Wei, S, Komrokji, R, Boultwood, J, List, A

    Published 2013
    Journal article
  9. 9
    Recurrent genetic defects on chromosome 5q in myeloid neoplasms

    Recurrent genetic defects on chromosome 5q in myeloid neoplasms by Hosono, N, Makishima, H, Mahfouz, R, Przychodzen, B, Yoshida, K, Jerez, A, LaFramboise, T, Polprasert, C, Clemente, M, Shiraishi, Y, Chiba, K, Tanaka, H, Miyano, S, Sanada, M, Cui, E, Verma, A, McDevitt, M, List, A, Saunthararajah, Y, Sekeres, M, Boultwood, J, Ogawa, S, Maciejewski, J

    Published 2016
    Journal article
  10. 10
    Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

    Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. by Zhou, L, Nguyen, A, Sohal, D, Ying, J, Pahanish, P, Gundabolu, K, Hayman, J, Chubak, A, Mo, Y, Bhagat, T, Das, B, Kapoun, A, Navas, T, Parmar, S, Kambhampati, S, Pellagatti, A, Braunchweig, I, Zhang, Y, Wickrema, A, Medicherla, S, Boultwood, J, Platanias, L, Higgins, L, List, A, Bitzer, M

    Published 2008
    Journal article
  11. 11
    Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.

    Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. by Jerez, A, Sugimoto, Y, Makishima, H, Verma, A, Jankowska, A, Przychodzen, B, Visconte, V, Tiu, R, O'Keefe, C, Mohamedali, A, Kulasekararaj, A, Pellagatti, A, McGraw, K, Muramatsu, H, Moliterno, A, Sekeres, M, McDevitt, M, Kojima, S, List, A, Boultwood, J, Mufti, G, Maciejewski, J

    Published 2012
    Journal article
  12. 12
    EUV sources for the alpha-tools - art. no. 61510Q

    EUV sources for the alpha-tools - art. no. 61510Q by Apetz, R, Bergmann, K, Damen, M, Derra, G, Franken, O, Janssen, M, Jonkers, J, Klein, J, Kraus, H, Kruecken, T, List, A, Loeken, M, Mader, A, Metzmacher, C, Neff, W, Probst, S, Pruemmer, R, Rosier, O, Schwabe, S, Seiwert, S, Siemons, G, Vaudrevange, D, Wagemann, D, Weber, A, Zink, P

    Published 2006
    Conference item
  13. 13
    Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.

    Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. by Will, B, Zhou, L, Vogler, T, Ben-Neriah, S, Schinke, C, Tamari, R, Yu, Y, Bhagat, T, Bhattacharyya, S, Barreyro, L, Heuck, C, Mo, Y, Parekh, S, McMahon, C, Pellagatti, A, Boultwood, J, Montagna, C, Silverman, L, Maciejewski, J, Greally, J, Ye, B, List, A, Steidl, C, Steidl, U, Verma, A

    Published 2012
    Journal article
  14. 14
    miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling.

    miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling. by Bhagat, T, Zhou, L, Sokol, L, Kessel, R, Caceres, G, Gundabolu, K, Tamari, R, Gordon, S, Mantzaris, I, Jodlowski, T, Yu, Y, Jing, X, Polineni, R, Bhatia, K, Pellagatti, A, Boultwood, J, Kambhampati, S, Steidl, U, Stein, C, Ju, W, Liu, G, Kenny, P, List, A, Bitzer, M, Verma, A

    Published 2013
    Conference item
  15. 15
    miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling

    miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling by Bhagat, T, Zhou, L, Sokol, L, Kessel, R, Caceres, G, Gundabolu, K, Tamari, R, Gordon, S, Mantzaris, I, Jodlowski, T, Yu, Y, Jing, X, Polineni, R, Bhatia, K, Pellagatti, A, Boultwood, J, Kambhampati, S, Steidl, U, Stein, C, Ju, W, Liu, G, Kenny, P, List, A, Bitzer, M, Verma, A

    Published 2013
    Journal article

Search Tools: